UBS has downgraded Ambev S.A. from 'Neutral' to 'Sell', raising alarms about the beverage company's financial outlook amid a year-over-year revenue decline of 3.78%. Currently trading at $3.29, Ambev's shares dipped by 0.15%, though they have rallied 32% over the past six months. Analysts are predicting an implied downside of 4.82% with a consensus price target of $3.04, while Seeking Alpha maintains a 'Buy' rating, reflecting mixed investor sentiment.
“ABEV · Earnings · $3.285 · -0.005”
“ABEV · Price Change Percentage · -0.15%”
“ABEV · Bid · $3.28 · X 108641”
“ABEV · Ask · $3.29 · X 72743”
“ABEV · Volume · 21,524,977.352179”
“ABEV · 52 Week Range · 2.10 - 3.45”
“ABEV · High/Low · 3.27 - 3.34”
“Ambev · engages in · the production, distribution, and sale of beverages”
“Ambev · operates through · geographical segments: Brazil, CAC, and Canada”
“Ambev (ABEV) reported Q1 2026 EPS of · $0.05, meeting estimates by · 8.00%”
“Ambev SA · engages in · production, distribution, and sale of beverages”
“Ambev SA · products include · beer, carbonated soft drinks, and other non-alcoholic and non-carbonated products”
